EarningsQ2 2023 Earnings Report

Actinogen Medical (3AC) Q2 2023 Earnings Report

0 Followers

DE:3AC Q2 2023 EPS Results

Actual EPS>-€0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS>-€0.01

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2023

Date02/21/2023

TimeAfter Close

Conference CallTuesday, February 21, 2023

DE:3AC Upcoming Earnings

Actinogen Medical 's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Feb 24, 2027	2027 (Q2)	- / -	-0.002	―
Aug 27, 2026	2026 (Q4)	- / >-0.01	-0.001	50.00% (<+0.01)
Feb 25, 2026	2026 (Q2)	- / >-0.01	-0.002	-33.33% (>-0.01)
Aug 25, 2025	2025 (Q4)	- / >-0.01	>-0.001	-100.00% (>-0.01)
Feb 24, 2025	2025 (Q2)	- / >-0.01	-0.004	50.00% (<+0.01)
Aug 30, 2024	2024 (Q4)	- / >-0.01	-0.001	50.00% (<+0.01)
Feb 25, 2024	2024 (Q2)	- / >-0.01	-0.002	-50.00% (>-0.01)
Aug 30, 2023	2023 (Q4)	- / >-0.01	-0.001	0.00% (0.00)
Feb 21, 2023	2023 (Q2)	- / >-0.01	-0.002	-33.33% (>-0.01)
Aug 25, 2022	2022 (Q4)	- / >-0.01	>-0.001	-100.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed